Global Pregabalin Market by Dosage Forms (Extended Release, Oral Capsule, Oral Solution), Drug Class (Anticonvulsants, Fibromyalgia Agents), Application, End-Users, Distribution Channel - Forecast 2024-2030- Product Image

Sale

Global Pregabalin Market by Dosage Forms (Extended Release, Oral Capsule, Oral Solution), Drug Class (Anticonvulsants, Fibromyalgia Agents), Application, End-Users, Distribution Channel - Forecast 2024-2030

Report
184 Pages
March 2024
Region: Global
360iResearch™
ID: 5666543

UP TO €851EUR$875USD£729GBP OFF until Dec 31^st 2024

The Pregabalin Market size was estimated at USD 1.12 billion in 2023, USD 1.20 billion in 2024, and is expected to grow at a CAGR of 7.74% to reach USD 1.89 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Pregabalin Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Pregabalin Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Pregabalin Market, highlighting leading vendors and their innovative profiles. These include Almelo Private Limited, Amneal Pharmaceuticals LLC, Aurobindo Pharma Limited, BAL Pharma Ltd., Cipla Limited, Dongbang FTL, Genesis Biotec Inc., Hikal Ltd., Lupin Limited, Medley Pharmaceuticals Limited, Novartis AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., and Zydus Lifesciences Limited.

Market Segmentation & Coverage

This research report categorizes the Pregabalin Market to forecast the revenues and analyze trends in each of the following sub-markets:

Dosage Forms
- Extended Release
- Oral Capsule
- Oral Solution
- Oral Tablet
Drug Class
- Anticonvulsants
- Fibromyalgia Agents
Application
- Anxiety Disorder
- Epilepsy
- Neuropathic Pain
End-Users
- Homecare
- Hospitals
- Research institute
- Specialty Clinics
Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

What is the market size and forecast of the Pregabalin Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Pregabalin Market?
What are the technology trends and regulatory frameworks in the Pregabalin Market?
What is the market share of the leading vendors in the Pregabalin Market?
Which modes and strategic moves are suitable for entering the Pregabalin Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Pregabalin Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing cases of epilepsy and anxiety disorders
5.1.1.2. Favorable government initiatives for raising awareness for anxiety issues
5.1.1.3. Rising geriartic population with neuropathic pain
5.1.2. Restraints
5.1.2.1. Presence of substitutes and lack of awareness
5.1.3. Opportunities
5.1.3.1. Rising approvals of generic versions of the medicine
5.1.3.2. Advancements and product enhancements for pregabalin
5.1.4. Challenges
5.1.4.1. Adverse effects on health and product recalls
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization

6. Pregabalin Market, by Dosage Forms

6.1. Introduction
6.2. Extended Release
6.3. Oral Capsule
6.4. Oral Solution
6.5. Oral Tablet

7. Pregabalin Market, by Drug Class

7.1. Introduction
7.2. Anticonvulsants
7.3. Fibromyalgia Agents

8. Pregabalin Market, by Application

8.1. Introduction
8.2. Anxiety Disorder
8.3. Epilepsy
8.4. Neuropathic Pain

9. Pregabalin Market, by End-Users

9.1. Introduction
9.2. Homecare
9.3. Hospitals
9.4. Research institute
9.5. Specialty Clinics

10. Pregabalin Market, by Distribution Channel

10.1. Introduction
10.2. Hospital Pharmacy
10.3. Online Pharmacy
10.4. Retail Pharmacy

11. Americas Pregabalin Market

11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Pregabalin Market

12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam

13. Europe, Middle East & Africa Pregabalin Market

13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom

14. Competitive Landscape

14.1. FPNV Positioning Matrix
14.2. Market Share Analysis, By Key Player
14.3. Competitive Scenario Analysis, By Key Player

15. Competitive Portfolio

15.1. Key Company Profiles
15.1.1. Almelo Private Limited
15.1.2. Amneal Pharmaceuticals LLC
15.1.3. Aurobindo Pharma Limited
15.1.4. BAL Pharma Ltd.
15.1.5. Cipla Limited
15.1.6. Dongbang FTL
15.1.7. Genesis Biotec Inc.
15.1.8. Hikal Ltd.
15.1.9. Lupin Limited
15.1.10. Medley Pharmaceuticals Limited
15.1.11. Novartis AG
15.1.12. Pfizer Inc.
15.1.13. Teva Pharmaceutical Industries Ltd.
15.1.14. Torrent Pharmaceuticals Ltd.
15.1.15. Zydus Lifesciences Limited
15.2. Key Product Portfolio

16. Appendix

16.1. Discussion Guide
16.2. License & Pricing

List of Figures

FIGURE 1. PREGABALIN MARKET RESEARCH PROCESS
FIGURE 2. PREGABALIN MARKET SIZE, 2022 VS 2030
FIGURE 3. PREGABALIN MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. PREGABALIN MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. PREGABALIN MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. PREGABALIN MARKET DYNAMICS
FIGURE 7. PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2022 VS 2030 (%)
FIGURE 8. PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. PREGABALIN MARKET SIZE, BY DRUG CLASS, 2022 VS 2030 (%)
FIGURE 10. PREGABALIN MARKET SIZE, BY DRUG CLASS, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. PREGABALIN MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
FIGURE 12. PREGABALIN MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. PREGABALIN MARKET SIZE, BY END-USERS, 2022 VS 2030 (%)
FIGURE 14. PREGABALIN MARKET SIZE, BY END-USERS, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2030 (%)
FIGURE 16. PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS PREGABALIN MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 18. AMERICAS PREGABALIN MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES PREGABALIN MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 20. UNITED STATES PREGABALIN MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC PREGABALIN MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC PREGABALIN MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA PREGABALIN MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA PREGABALIN MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 25. PREGABALIN MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 26. PREGABALIN MARKET SHARE, BY KEY PLAYER, 2022

List of Tables

TABLE 1. PREGABALIN MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. PREGABALIN MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PREGABALIN MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 6. PREGABALIN MARKET SIZE, BY EXTENDED RELEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. PREGABALIN MARKET SIZE, BY ORAL CAPSULE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. PREGABALIN MARKET SIZE, BY ORAL SOLUTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. PREGABALIN MARKET SIZE, BY ORAL TABLET, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 11. PREGABALIN MARKET SIZE, BY ANTICONVULSANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. PREGABALIN MARKET SIZE, BY FIBROMYALGIA AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 14. PREGABALIN MARKET SIZE, BY ANXIETY DISORDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. PREGABALIN MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. PREGABALIN MARKET SIZE, BY NEUROPATHIC PAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 18. PREGABALIN MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. PREGABALIN MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. PREGABALIN MARKET SIZE, BY RESEARCH INSTITUTE, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. PREGABALIN MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 23. PREGABALIN MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. PREGABALIN MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. PREGABALIN MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS PREGABALIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 42. CANADA PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 43. CANADA PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 44. CANADA PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 45. CANADA PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 46. CANADA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 47. MEXICO PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 48. MEXICO PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 49. MEXICO PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. MEXICO PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 51. MEXICO PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES PREGABALIN MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 58. ASIA-PACIFIC PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 62. ASIA-PACIFIC PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 63. ASIA-PACIFIC PREGABALIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 64. AUSTRALIA PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 65. AUSTRALIA PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 66. AUSTRALIA PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. AUSTRALIA PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 68. AUSTRALIA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 69. CHINA PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 70. CHINA PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 71. CHINA PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. CHINA PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 73. CHINA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 74. INDIA PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 75. INDIA PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 76. INDIA PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. INDIA PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 78. INDIA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 79. INDONESIA PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 80. INDONESIA PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 81. INDONESIA PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. INDONESIA PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 83. INDONESIA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 84. JAPAN PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 85. JAPAN PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 86. JAPAN PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. JAPAN PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 88. JAPAN PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 89. MALAYSIA PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 90. MALAYSIA PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 91. MALAYSIA PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. MALAYSIA PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 93. MALAYSIA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 94. PHILIPPINES PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 95. PHILIPPINES PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 96. PHILIPPINES PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. PHILIPPINES PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 98. PHILIPPINES PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 99. SINGAPORE PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 100. SINGAPORE PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 101. SINGAPORE PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. SINGAPORE PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 103. SINGAPORE PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 104. SOUTH KOREA PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 105. SOUTH KOREA PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 106. SOUTH KOREA PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. SOUTH KOREA PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 108. SOUTH KOREA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 109. TAIWAN PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 110. TAIWAN PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 111. TAIWAN PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. TAIWAN PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 113. TAIWAN PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 114. THAILAND PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 115. THAILAND PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 116. THAILAND PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. THAILAND PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 118. THAILAND PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 119. VIETNAM PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 120. VIETNAM PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 121. VIETNAM PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. VIETNAM PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 123. VIETNAM PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA PREGABALIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 130. DENMARK PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 131. DENMARK PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 132. DENMARK PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. DENMARK PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 134. DENMARK PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 135. EGYPT PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 136. EGYPT PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 137. EGYPT PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. EGYPT PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 139. EGYPT PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 140. FINLAND PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 141. FINLAND PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 142. FINLAND PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. FINLAND PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 144. FINLAND PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 145. FRANCE PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 146. FRANCE PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 147. FRANCE PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 148. FRANCE PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 149. FRANCE PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 150. GERMANY PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 151. GERMANY PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 152. GERMANY PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. GERMANY PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 154. GERMANY PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 155. ISRAEL PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 156. ISRAEL PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 157. ISRAEL PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. ISRAEL PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 159. ISRAEL PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 160. ITALY PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 161. ITALY PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 162. ITALY PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. ITALY PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 164. ITALY PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 165. NETHERLANDS PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 166. NETHERLANDS PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 167. NETHERLANDS PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 168. NETHERLANDS PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 169. NETHERLANDS PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 170. NIGERIA PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 171. NIGERIA PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 172. NIGERIA PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. NIGERIA PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 174. NIGERIA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 175. NORWAY PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 176. NORWAY PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 177. NORWAY PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. NORWAY PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 179. NORWAY PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 180. POLAND PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 181. POLAND PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 182. POLAND PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 183. POLAND PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 184. POLAND PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 185. QATAR PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 186. QATAR PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 187. QATAR PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 188. QATAR PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 189. QATAR PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 196. SAUDI ARABIA PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 198. SAUDI ARABIA PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 205. SPAIN PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 206. SPAIN PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 207. SPAIN PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 208. SPAIN PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 209. SPAIN PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 210. SWEDEN PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 211. SWEDEN PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 212. SWEDEN PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 213. SWEDEN PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 214. SWEDEN PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 215. SWITZERLAND PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 216. SWITZERLAND PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 217. SWITZERLAND PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 218. SWITZERLAND PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 219. SWITZERLAND PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 220. TURKEY PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 221. TURKEY PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 222. TURKEY PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 223. TURKEY PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 224. TURKEY PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 230. UNITED KINGDOM PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM PREGABALIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 234. UNITED KINGDOM PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 235. PREGABALIN MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 236. PREGABALIN MARKET SHARE, BY KEY PLAYER, 2022
TABLE 237. PREGABALIN MARKET LICENSE & PRICING

Companies Mentioned

Almelo Private Limited
Amneal Pharmaceuticals LLC
Aurobindo Pharma Limited
BAL Pharma Ltd.
Cipla Limited
Dongbang FTL
Genesis Biotec Inc.
Hikal Ltd.
Lupin Limited
Medley Pharmaceuticals Limited
Novartis AG
Pfizer Inc.
Teva Pharmaceutical Industries Ltd.
Torrent Pharmaceuticals Ltd.
Zydus Lifesciences Limited

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	184
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 1.2 Billion
Forecasted Market Value ( USD ) by 2030	$ 1.89 Billion
Compound Annual Growth Rate	7.7%
Regions Covered	Global
No. of Companies Mentioned	15

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3283EUR$3,374USD£2,812GBP €3648EUR$3,749USD£3,125GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4159EUR$4,274USD£3,562GBP €4621EUR$4,749USD£3,958GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€5034EUR$5,174USD£4,313GBP €5594EUR$5,749USD£4,792GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5910EUR$6,074USD£5,063GBP €6567EUR$6,749USD£5,625GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7661EUR$7,874USD£6,563GBP €8513EUR$8,749USD£7,292GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Pregabalin - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

Pregabalin Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

Pregabalin (API) Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

Pregabalin (CAS 148553-50-8) Global Market Research Report 2024

Global Ankylosing Spondylitis Market by Drug (Cimzia, Cosentyx, Enbrel), Type of Molecule (Biologics, Small Molecules), Mechanism Of Action, Route Of Administration, Dosage Forms, End User - Forecast 2024-2030

About the Pregabalin Market